Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7722350

Concept As at
2018-06-30
2018-04-01 to
2018-06-30
As at
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2017-06-30
As at
2017-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
11,357,000,000 JPY
45,900,000,000 JPY
11,509,000,000 JPY
Ordinary profit (loss)
363,000,000 JPY
832,000,000 JPY
278,000,000 JPY
Profit (loss)
235,000,000 JPY
970,000,000 JPY
192,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
Net assets
32,422,000,000 JPY
32,579,000,000 JPY
32,447,000,000 JPY
Total assets
71,395,000,000 JPY
70,188,000,000 JPY
69,481,000,000 JPY
Dividend paid per share
80.00
Basic earnings (loss) per share
26.85
109.61
21.49
Diluted earnings per share
Equity-to-asset ratio
0.454 xbrli:pure
0.464 xbrli:pure
0.467 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.